New Flinque AI now scores creator authenticity in real time across 12 platforms. See how

Candid Founder CEO Nick Greenfield: The Profile

Founder Profile

Nick Greenfield and Candid

The Lyft-to-aligners career path, the $6,000 markup that sparked the idea, the hard DTC-to-B2B pivot in 2022, plus the direct-to-consumer marketing lessons worth keeping.

✍︎ Flinque Research Team 📅 Published Jun 2026 🔄 Updated Jun 04, 2026 7 min read
$200 to $6,000
The aligner production cost versus retail markup that sparked Candid
Launched 2017
Candid started as a direct-to-consumer clear aligner brand
2022 B2B pivot
Candid closed DTC plus 45 studios to focus on CandidPro telehealth
Ex-Lyft, ex-Paribus
Greenfield's operating background before founding Candid

Introduction

Nick Greenfield did not set out to disrupt orthodontics. He grew up in Washington DC expecting a career in diplomacy or politics, spent his early career as an early Lyft employee plus later as COO of a startup acquired by Capital One, then stumbled onto a pricing gap that became a company. The gap: clear aligners that cost a couple hundred dollars to manufacture were retailing for roughly $6,000. Greenfield co-founded Candid in 2017 to close that gap, built it into a direct-to-consumer brand nicknamed the Warby Parker of braces, then made one of the harder calls in DTC by closing the entire consumer business in 2022 to bet on a B2B telehealth model instead.

Here is who Greenfield is, how Candid started, what the company became after its 2022 pivot, the market context behind the opportunity, plus the direct-to-consumer marketing lessons that translate to any brand chasing creator-led growth.

Free toolkit · 28 pages

The Creator Outreach Toolkit

12 email templates that get replies, a 50-point creator vetting checklist, rate negotiation scripts and a campaign tracker. Built from 4 years of running creator campaigns.

Check your inbox in 2 minutes. Or open the toolkit now →
Something went wrong. Open the toolkit directly →

Who Nick Greenfield is

The operating background matters because it shaped how Candid was built.

Nick Greenfield is the co-founder plus CEO of Candid. Before Candid, he was one of the earliest Lyft employees, helping launch eight markets starting with San Francisco plus moving through Los Angeles, Seattle, Boston plus Washington DC, which gave him operational experience scaling a marketplace business across geographies. He then served as COO at Paribus, a price-tracking startup acquired by Capital One. Greenfield also helped start Redesign Health, a healthcare venture studio that has raised significant capital since inception plus launched multiple companies ideated internally. Per his own account, he grew up in the Washington DC area amid the political scene plus expected to go into diplomacy or politics rather than entrepreneurship. The marketplace-scaling experience from Lyft plus the price-disruption thinking from Paribus both show up in how Candid approached the orthodontics category: build a tech-forward platform, attack an inflated price point, scale across markets methodically.

The founding story

Three factors aligned in early 2017 to make Candid possible.

The first was the pricing insight. Per Greenfield's account across multiple interviews, his aha moment came when he discovered that clear aligners cost only a couple hundred dollars to manufacture yet retailed to consumers for roughly $6,000. He described thinking there had to be a better way to deliver the same outcome. The second factor was clinical access: around the same time he connected with the person who became Candid's chairman, whose father was an orthodontist plus who understood the treatment modality plus cost structure of the category from the inside. The third factor was timing. Align Technology, the maker of Invisalign since 1999, had patented using computer software to predict how teeth would move, which had blocked every other clear aligner company from using software-driven treatment planning. Those foundational patents were set to roll off in October 2017. The patent expiry opened the category to software-driven competitors for the first time. Greenfield noticed his own teeth had shifted after he started working, with his bottom teeth overlapping in ways that made flossing harder, which gave him personal motivation alongside the business opportunity. Candid launched in 2017 built on accessibility plus affordability, underpinned by software plus a tech-forward treatment platform.

What Candid is and the 2022 pivot

Candid started as one thing plus became another, which is the most instructive part of the story.

Candid launched in 2017 as a direct-to-consumer clear aligner brand. Customers could get their teeth scanned at physical Candid studios or use an at-home impression kit, then receive aligners shipped to them with remote monitoring. The DTC model scaled fast, reaching 45 studio locations plus building the Warby Parker of braces brand positioning. Then in January 2022, Candid closed its entire direct-to-consumer business plus all 45 studio locations, pivoting fully into CandidPro, its business-to-business telehealth service. CandidPro lets dentists, dental support organisations plus orthodontists treat clear aligner cases remotely while keeping a licensed doctor in the loop, which Candid positioned as both better clinical care plus a revenue generator for dental practices. Per Greenfield's statements at the time, the pivot reflected five years of DTC learning: patients loved the convenience but also wanted in-person doctor oversight. Per the company's own reporting, CandidPro had grown roughly 10 times in case volume plus revenue since the third quarter of 2021 before the pivot, which gave the team confidence the B2B model had stronger product-market fit. Per Tracxn data, Candid has raised roughly $148 million total across five rounds from 23 investors, employing roughly 304 people as of January 2026. The company differentiates against Invisalign on doctor-driven care, affordability, attachment-free treatment plus remote monitoring. Treat all financial plus headcount figures as third-party-reported rather than company-confirmed.

The market context

The opportunity Greenfield spotted sits on top of a large underserved market.

Per industry estimates cited in founder coverage, roughly 65 to 75 percent of the global population has some degree of malocclusion (misaligned teeth), yet only around 15 million people per year seek orthodontic treatment. For most people, even in high-income countries, traditional orthodontic treatment options have been price-prohibitive at the historical $6,000 range. The clear aligner category that Candid plus competitors built attacks that gap by reducing the price of orthodontic treatment through plastic aligners plus tech-forward platforms. The category has seen significant competition plus consolidation, with some prominent direct-to-consumer aligner companies expanding rapidly before facing financial difficulties, which is part of why Candid's pivot toward the doctor-supervised B2B model looks prescient in hindsight. The shift from pure DTC convenience toward clinical oversight reflects a broader pattern in health-adjacent DTC categories, where the initial convenience-first model often gives way to models that keep licensed professionals in the loop. Treat all market-size percentages as industry estimates rather than precise audited figures.

The DTC marketing lessons

Four lessons translate from Candid's trajectory to any brand chasing direct-to-consumer growth.

First, pricing gaps signal opportunity. The $200-to-$6,000 aligner markup was the founding insight, plus similar production-to-retail gaps exist across categories where incumbents have protected margins behind patents or distribution control. Founders who hunt for these gaps find genuine openings. Second, regulatory plus patent timing creates windows. Candid's launch aligned deliberately with the Invisalign patent expiry, plus founders who track when category-defining patents roll off can time market entry to coincide with the opening. Third, product-market fit can point somewhere other than the original plan. Candid's DTC business taught the company the B2B telehealth model fit better, plus the discipline to close a 45-studio consumer operation to chase the stronger model is what separates durable companies from ones clinging to the original thesis. Fourth, DTC brands grow on creator marketing. Candid's consumer-facing era leaned heavily on the same playbook every DTC challenger brand runs: creator partnerships, social-first content plus influencer-driven trial. The Warby Parker comparison was not just about price disruption, it was about the brand-building model, plus that model runs through creators reaching the right audiences at the right scale.

Where Flinque fits

The fourth lesson is where creator discovery connects. DTC challenger brands like Candid in its consumer era grow through creator partnerships: finding the right creators, seeding product, building social proof plus driving trial at a cost structure that traditional advertising cannot match. The discovery problem (finding the right creators in the right niches at the right scale) is the part that scales worst through manual effort.

Flinque is one option for that discovery layer, approaching this from the discovery side. The platform holds north of 10 million verified creators spread over 25-plus countries, reachable on Instagram, TikTok, YouTube and X. You filter by category (health, beauty, lifestyle plus the verticals where DTC brands concentrate), who the audience really is, follower tier, engagement strength and home region. Fake-follower screening runs on every profile before it lands in your results. It is free to begin or $49 a month for the paid plan, which fits the lean budgets DTC challenger brands run early on. Honest scope: Flinque finds the creators. It does not manage the seeding logistics, does not run the contracts, does not handle the content production that a full DTC creator programme needs. For founders building the next price-disrupting DTC brand, the creator discovery layer is where the audience-finding work starts, plus it is the layer that determines whether the rest of the playbook has the right people to run through.

Flinque

Building a DTC brand that needs creator-led growth?

Flinque is creator discovery and vetting across Instagram, YouTube, TikTok and X, from $49 monthly. Start free with no credit card.

Final thoughts

The takeaway

Reaching YouTube creators by email works best when you combine methodical research, ethical sourcing and respectful communication. Focus on publicly shared, business-oriented YouTube channel contact points and clear, value-driven proposals.

Over time, thoughtful YouTube influencer email outreach can build reliable, mutually beneficial relationships with channels across many niches. The brands that win long-term creator partnerships are those that treat outreach as relationship-building. Not just a numbers game.

Next step

Skip the 20-step manual lookup for every creator. and pull 50 verified creator emails in under a minute.

FAQs

Common questions about YouTube creator email lookup

Quick answers to the questions brands and marketers ask most often.

Who is Nick Greenfield?

The co-founder plus CEO of Candid, a clear aligner company often nicknamed the Warby Parker of braces. Before Candid, Greenfield was an early Lyft employee who helped launch eight markets including San Francisco, Los Angeles, Seattle, Boston plus Washington DC. He then served as COO at Paribus, a price-tracking startup acquired by Capital One. He also helped start Redesign Health, a healthcare venture studio that has raised significant capital plus launched multiple companies. Per his own account, Greenfield grew up in the Washington DC area expecting a career in diplomacy or politics rather than entrepreneurship. He founded Candid in 2017 after spotting an unusual gap between the production cost plus the retail price of clear aligners.

How did Candid get started?

Per Greenfield's own account across multiple interviews, the founding insight came in early 2017 when he discovered that clear aligners cost only a couple hundred dollars to manufacture yet retailed to consumers for roughly $6,000. That gap struck him as a clear sign the category was overdue for disruption. Around the same time he connected with the person who became Candid's chairman, whose father was an orthodontist plus who understood the clinical side of the category. A third factor mattered: Align Technology's foundational Invisalign patents from 1999, which had blocked competitors from using computer software to predict tooth movement, were set to roll off in October 2017. The patent expiry opened the category to new entrants. Candid launched in 2017 as a direct-to-consumer aligner brand built on accessibility plus affordability.

Why did Candid pivot from DTC to B2B?

In January 2022, Candid closed its direct-to-consumer business plus all 45 of its physical studio locations, pivoting fully into CandidPro, its business-to-business telehealth service for dentists, dental support organisations plus orthodontists. Per Greenfield's statements at the time, the pivot reflected what the company learned across five years of DTC operation: patients loved the convenience but also wanted the reassurance of in-person doctor oversight. CandidPro lets dental practices treat clear aligner cases remotely while keeping a doctor in the loop, which the company positioned as both better clinical care plus a revenue generator for practices. Per the company's own reporting at the time, CandidPro had grown roughly 10 times in case volume plus revenue since the third quarter of 2021, which gave Greenfield confidence the B2B model had stronger product-market fit than the DTC business.

How much funding has Candid raised?

Per Tracxn data, Candid has raised roughly $148 million total across five rounds from 23 investors as of early 2026. Earlier reporting documented a $15 million Series A led by Greycroft plus broader backing from investors including Bessemer, with the company having raised more than $70 million in its earlier DTC phase. The company employed roughly 304 people as of January 2026 per Tracxn. Treat all funding plus headcount figures as third-party-reported rather than company-confirmed, since private-company financials are not independently audited plus reporting sources vary in their totals depending on which rounds they include.

What can DTC founders learn from Candid's trajectory?

Three lessons recur. First, pricing gaps signal opportunity: the $200-to-$6,000 aligner markup was the founding insight, plus similar production-to-retail gaps exist across many categories where incumbents have protected margins. Second, regulatory plus patent timing creates windows: Candid's launch aligned with the Invisalign patent expiry, plus founders who track when category-defining patents roll off can time market entry. Third, product-market fit can point somewhere other than the original plan: Candid's DTC business taught the company that the B2B telehealth model fit better, plus the willingness to close a 45-studio DTC operation to chase the stronger model is the kind of pivot discipline that separates durable companies from ones that cling to the original thesis. For marketers specifically, Candid's DTC era was a creator-marketing-heavy growth playbook, which is the fourth lesson worth keeping.

Written & reviewed by Flinque Research Team

Influencer Marketing Analysts · View team →

Our research team specialises in influencer marketing strategy, creator analytics and outreach best practices. All content is reviewed for accuracy using live platform data and current industry standards.

📧 Creator outreach 📺 YouTube strategy 🔍 Contact research 🗓 Updated Jun 04 2026

Disclaimer: All information on this page is collected from publicly available sources, third-party search engines, AI-powered tools and general online research. We do not claim ownership of any external data and accuracy may vary. This content is for informational purposes only.